Brain power on display at the Franklin Institute Image: Courtesy of the Franklin Institute Brain power on display at the Franklin Institute Several researchers from Penn Medicine’s Department of Neurology are featured throughout the Franklin Institute’s Body Odyssey exhibit. 1 min. read
Clinician nudge at suspected ovarian cancer diagnosis improves oncology referral rate Penn In the News Healio Clinician nudge at suspected ovarian cancer diagnosis improves oncology referral rate A study by Anna Jo Smith of the Perelman School of Medicine and colleagues found that a clinician nudge for referral to a gynecologic oncologist at the time of a suspected ovarian cancer diagnosis improved referral rates by 20%. A child who got CAR-T cancer therapy is still disease-free 18 years later Penn In the News Science News A child who got CAR-T cancer therapy is still disease-free 18 years later Carl June of the Perelman School of Medicine says that neuroblastoma is the first solid tumor for which there could be curative effects with CAR T cells. The U.S. is losing its next generation of health scientists Penn In the News The Hill The U.S. is losing its next generation of health scientists In a co-written opinion essay, James Alwine of the Perelman School of Medicine says that slashing of research funding for NIH and the National Science Foundation will eliminate the next generation of health scientists. Text message tool addresses ‘time toxicity’ for cancer patients Image: iStock/andreswd Text message tool addresses ‘time toxicity’ for cancer patients In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology. No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy. The compassionate team behind CAR T cancer breakthroughs (From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.(Image: Courtesy of Penn Medicine News) The compassionate team behind CAR T cancer breakthroughs The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside. New ways to modulate cell activity remotely Cells are dynamic, fast-changing, complex, tiny, and often hard-to-see in environments that don’t always behave in predictable ways when exposed to external stimuli. Now, researchers led by Lukasz Bugaj of the School of Engineering and Applied Science have found new ways to modulate cell activity remotely.(Image: iStock/Maksim Tkachenko) New ways to modulate cell activity remotely Penn researchers use temperature to guide cellular behavior, promising better diagnostics and targeted therapies. Scientists create tiny anticancer weapons that make tumors destroy themselves Penn In the News Interesting Engineering Scientists create tiny anticancer weapons that make tumors destroy themselves Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells. Developing a tiny anticancer weapon Image: iStock/Bahaa_Aladdin Developing a tiny anticancer weapon Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests. Load More
A child who got CAR-T cancer therapy is still disease-free 18 years later Penn In the News Science News A child who got CAR-T cancer therapy is still disease-free 18 years later Carl June of the Perelman School of Medicine says that neuroblastoma is the first solid tumor for which there could be curative effects with CAR T cells. The U.S. is losing its next generation of health scientists Penn In the News The Hill The U.S. is losing its next generation of health scientists In a co-written opinion essay, James Alwine of the Perelman School of Medicine says that slashing of research funding for NIH and the National Science Foundation will eliminate the next generation of health scientists. Text message tool addresses ‘time toxicity’ for cancer patients Image: iStock/andreswd Text message tool addresses ‘time toxicity’ for cancer patients In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology. No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy. The compassionate team behind CAR T cancer breakthroughs (From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.(Image: Courtesy of Penn Medicine News) The compassionate team behind CAR T cancer breakthroughs The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside. New ways to modulate cell activity remotely Cells are dynamic, fast-changing, complex, tiny, and often hard-to-see in environments that don’t always behave in predictable ways when exposed to external stimuli. Now, researchers led by Lukasz Bugaj of the School of Engineering and Applied Science have found new ways to modulate cell activity remotely.(Image: iStock/Maksim Tkachenko) New ways to modulate cell activity remotely Penn researchers use temperature to guide cellular behavior, promising better diagnostics and targeted therapies. Scientists create tiny anticancer weapons that make tumors destroy themselves Penn In the News Interesting Engineering Scientists create tiny anticancer weapons that make tumors destroy themselves Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells. Developing a tiny anticancer weapon Image: iStock/Bahaa_Aladdin Developing a tiny anticancer weapon Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests. Load More
The U.S. is losing its next generation of health scientists Penn In the News The Hill The U.S. is losing its next generation of health scientists In a co-written opinion essay, James Alwine of the Perelman School of Medicine says that slashing of research funding for NIH and the National Science Foundation will eliminate the next generation of health scientists. Text message tool addresses ‘time toxicity’ for cancer patients Image: iStock/andreswd Text message tool addresses ‘time toxicity’ for cancer patients In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology. No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy. The compassionate team behind CAR T cancer breakthroughs (From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.(Image: Courtesy of Penn Medicine News) The compassionate team behind CAR T cancer breakthroughs The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside. New ways to modulate cell activity remotely Cells are dynamic, fast-changing, complex, tiny, and often hard-to-see in environments that don’t always behave in predictable ways when exposed to external stimuli. Now, researchers led by Lukasz Bugaj of the School of Engineering and Applied Science have found new ways to modulate cell activity remotely.(Image: iStock/Maksim Tkachenko) New ways to modulate cell activity remotely Penn researchers use temperature to guide cellular behavior, promising better diagnostics and targeted therapies. Scientists create tiny anticancer weapons that make tumors destroy themselves Penn In the News Interesting Engineering Scientists create tiny anticancer weapons that make tumors destroy themselves Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells. Developing a tiny anticancer weapon Image: iStock/Bahaa_Aladdin Developing a tiny anticancer weapon Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests. Load More
Text message tool addresses ‘time toxicity’ for cancer patients Image: iStock/andreswd Text message tool addresses ‘time toxicity’ for cancer patients In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.
No evidence that CAR T cell therapy causes secondary cancers Image: Courtesy of Penn Medicine No evidence that CAR T cell therapy causes secondary cancers In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.
The compassionate team behind CAR T cancer breakthroughs (From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.(Image: Courtesy of Penn Medicine News) The compassionate team behind CAR T cancer breakthroughs The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.
New ways to modulate cell activity remotely Cells are dynamic, fast-changing, complex, tiny, and often hard-to-see in environments that don’t always behave in predictable ways when exposed to external stimuli. Now, researchers led by Lukasz Bugaj of the School of Engineering and Applied Science have found new ways to modulate cell activity remotely.(Image: iStock/Maksim Tkachenko) New ways to modulate cell activity remotely Penn researchers use temperature to guide cellular behavior, promising better diagnostics and targeted therapies.
Scientists create tiny anticancer weapons that make tumors destroy themselves Penn In the News Interesting Engineering Scientists create tiny anticancer weapons that make tumors destroy themselves Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells. Developing a tiny anticancer weapon Image: iStock/Bahaa_Aladdin Developing a tiny anticancer weapon Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.
Developing a tiny anticancer weapon Image: iStock/Bahaa_Aladdin Developing a tiny anticancer weapon Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.